For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220810:nRSJ4773Va&default-theme=true
RNS Number : 4773V Accrol Group Holdings PLC 10 August 2022
10 August 2022
ACCROL GROUP HOLDINGS PLC
("Accrol" or the "Group")
AIM: ACRL
Notice of Final Results and Online Presentations
Accrol, the UK's leading independent tissue converter, announces that it will
release its Final Results for the year ended 30 April 2022 on Tuesday, 6
September 2022.
An analyst briefing will be held online at 9.00 am on that day. Equity
analysts interested in joining the meeting should contact Belvedere
Communications.
As part of the Group's Results roadshow, the management will host an online
investor presentation and Q&A session. This will take place on Wednesday,
7 September 2022 at 12.30pm. Anyone wishing to participate should register for
the event with PI World at: https://bit.ly/ACRL_FY22
(https://bit.ly/ACRL_FY22) .
For further information, please contact:
Accrol Group Holdings plc Via Belvedere Communications
Dan Wright, Executive Chairman
Gareth Jenkins, Chief Executive Officer
Richard Newman, Chief Financial Officer
Zeus (Nominated Adviser & Broker)
Dan Bate / Jordan Warburton (Investment Banking) Tel: +44 (0) 161 831 1512
Dominic King (Corporate Broking) Tel: +44 (0) 203 829 5000
Liberum Capital Limited (Joint Broker)
Clayton Bush / Edward Thomas Tel: +44 (0) 20 3100 2222
Belvedere Communications Limited
Cat Valentine Tel: +44 (0) 7715 769 078
Keeley Clarke Tel: +44 (0) 7967 816 525
accrolpr@belvederepr.com (mailto:accrolpr@belvederepr.com)
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet
tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's
leading discounters and grocery retailers across the UK. Following the recent
acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now
operates from six manufacturing sites, including four in Lancashire, which
generate revenues totalling c.16% of the £2.1bn UK retail tissue market.
For more information, please visit www.accrol.co.uk (http://www.accrol.co.uk)
.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NORDGGDIRBGDGDC